Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Achieving cholesterol target in a managed care organization (ACTION) trial.

Straka RJ, Taheri R, Cooper SL, Smith JC.

Pharmacotherapy. 2005 Mar;25(3):360-71.

PMID:
15843283
2.

Assessing the results: phase 1 hyperlipidemia outcomes in 27 health plans.

Latts LM.

Am J Med. 2001 Apr 16;110 Suppl 6A:17S-23S. Review.

PMID:
11311193
3.

Cholesterol: precursor to many lipid disorders.

Jones PH.

Am J Manag Care. 2001 Aug;7(9 Suppl):S289-98. Review.

4.

Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.

Daskalopoulou SS, Mikhailidis DP.

Curr Med Res Opin. 2006 Mar;22(3):511-28. Review.

PMID:
16574035
5.

Cholesterol-lowering drugs bring benefits to high-risk populations even when LDL is normal.

Braun LT, Davidson MH.

J Cardiovasc Nurs. 2003 Jan-Mar;18(1):44-9; quiz 75-6. Review.

PMID:
12537089
6.

Low density lipoprotein cholesterol lowering: are the treatment guidelines still appropriate?

Deslypere JP.

Int J Clin Pract. 2000 Jun;54(5):307-13. Review.

PMID:
10954957
7.

Cost of a pharmacist-directed intervention to increase treatment of hypercholesterolemia.

Hilleman DE, Faulkner MA, Monaghan MS.

Pharmacotherapy. 2004 Aug;24(8):1077-83. Review.

PMID:
15338855
8.

Critical appraisal of revised cholesterol guidelines for the very high-risk patient.

Rosenson R, Lloyd-Jones D; Working group from the Adult Treatment Panel III of the National Cholesterol Educational Program.

Expert Rev Cardiovasc Ther. 2005 Jan;3(1):173-8. Review.

PMID:
15739256
9.

Are we aggressive enough in lowering cholesterol?

Waters DD.

Am J Cardiol. 2001 Aug 16;88(4A):10F-5F. Review.

PMID:
11520481
10.

Lipid-lowering interventions in managed care settings.

Fox J, Jones K.

Am J Med. 2001 Apr 16;110 Suppl 6A:24S-30S. Review.

PMID:
11311194
11.

Clinical context: current concepts of coronary heart disease management.

Jacobson TA.

Am J Med. 2001 Apr 16;110 Suppl 6A:3S-11S. Review.

PMID:
11311191
12.
13.

Cholesterol. How low should we go?

Chamsi-Pasha H.

Saudi Med J. 2005 Jan;26(1):11-8. Review.

PMID:
15756346
14.
15.

Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials.

Santschi V, Chiolero A, Burnand B, Colosimo AL, Paradis G.

Arch Intern Med. 2011 Sep 12;171(16):1441-53. doi: 10.1001/archinternmed.2011.399. Review.

PMID:
21911628
16.

Effective management of patients with dyslipidemia.

Lipsy RJ.

Am J Manag Care. 2003 Feb;9(2 Suppl):S39-58. Review.

17.

Improving cholesterol control in managed care populations.

McKenney JM.

Am J Manag Care. 2000 Nov;6(19 Suppl):S997-1007. Review.

18.

Asessing coronary heart disease risk and managing lipids.

Braun LT, Rosenson RS.

Nurse Pract. 2001 Dec;26(12):30-2, 34, 37-41; quiz 42-3. Review.

PMID:
11809040
19.

Clinical inquiries. Which patients benefit from lowering LDL to <100 mg/dL?

Evensen A, Elliott M, Hooper-Lane C.

J Fam Pract. 2010 Dec;59(12):706-8. Review.

PMID:
21135927
20.

A means to an end: an overview of a hyperlipidemia outcomes management program.

Patel B, Perez HE.

Am J Med. 2001 Apr 16;110 Suppl 6A:12S-16S. Review.

PMID:
11311192

Supplemental Content

Support Center